121 related articles for article (PubMed ID: 38417352)
1. Evaluation of C4d expression and staining patterns by immunohistochemistry in renal biopsy samples with focal segmental glomerulosclerosis and minimal change disease.
Abedi M; Nili F; Dehkhoda F; Abdollahi A; Salarvand S
Ann Diagn Pathol; 2024 Jun; 70():152281. PubMed ID: 38417352
[TBL] [Abstract][Full Text] [Related]
2. Glomerular C4d deposition can precede the development of focal segmental glomerulosclerosis.
van de Lest NA; Zandbergen M; Wolterbeek R; Kreutz R; Trouw LA; Dorresteijn EM; Bruijn JA; Bajema IM; Scharpfenecker M; Chua JS
Kidney Int; 2019 Sep; 96(3):738-749. PubMed ID: 31327475
[TBL] [Abstract][Full Text] [Related]
3. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
Pereira LHM; da Silva CA; Monteiro MLGDR; Araújo LS; Rocha LP; Reis MBDR; Ramalho FS; Corrêa RRM; Silva MV; Reis MA; Machado JR
PLoS One; 2019; 14(6):e0217569. PubMed ID: 31188898
[TBL] [Abstract][Full Text] [Related]
4. Mesangial C4d deposition is independently associated with poor renal survival in patients with primary focal segmental glomerulosclerosis.
Heybeli C; Oktan MA; Yıldız S; Ünlü M; Celik A; Sarıoglu S
Clin Exp Nephrol; 2019 May; 23(5):650-660. PubMed ID: 30617839
[TBL] [Abstract][Full Text] [Related]
5. Expression of DENDRIN in several glomerular diseases and correlation to pathological parameters and renal failure - preliminary study.
Mizdrak M; Vukojević K; Filipović N; Čapkun V; Benzon B; Durdov MG
Diagn Pathol; 2018 Nov; 13(1):90. PubMed ID: 30458823
[TBL] [Abstract][Full Text] [Related]
6. Renal pathology in hematopoietic cell transplant recipients: a contemporary biopsy, nephrectomy, and autopsy series.
Brinkerhoff BT; Houghton DC; Troxell ML
Mod Pathol; 2016 Jun; 29(6):637-52. PubMed ID: 27015134
[TBL] [Abstract][Full Text] [Related]
7. Glomerular malondialdehyde levels in patients with focal and segmental glomerulosclerosis and minimal change disease.
Nezhad ST; Momeni B; Basiratnia M
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):886-91. PubMed ID: 20814126
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
[TBL] [Abstract][Full Text] [Related]
9. Differential deposition of C4d and MBL in glomeruli of patients with ANCA-negative pauci-immune crescentic glomerulonephritis.
Xing GQ; Chen M; Liu G; Zheng X; E J; Zhao MH
J Clin Immunol; 2010 Jan; 30(1):144-56. PubMed ID: 19898926
[TBL] [Abstract][Full Text] [Related]
10. [Minimal change disease and focal segmental glomerulosclerosis in children--histomorphometric comparative study with application to computer image analysis].
Danilewicz M; Wagrowska-Danilewicz M
Przegl Lek; 1996; 53(7):529-33. PubMed ID: 8975287
[TBL] [Abstract][Full Text] [Related]
11. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
[TBL] [Abstract][Full Text] [Related]
12. Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease.
Smeets B; Stucker F; Wetzels J; Brocheriou I; Ronco P; Gröne HJ; D'Agati V; Fogo AB; van Kuppevelt TH; Fischer HP; Boor P; Floege J; Ostendorf T; Moeller MJ
Am J Pathol; 2014 Dec; 184(12):3239-48. PubMed ID: 25307344
[TBL] [Abstract][Full Text] [Related]
13. Minimal change disease and idiopathic focal segmental glomerulosclerosis in adults. A quantitative study.
Danilewicz M; Wagrowska-Danilewicz M
Pol J Pathol; 1996; 47(4):209-14. PubMed ID: 9097714
[TBL] [Abstract][Full Text] [Related]
14. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G/albumin staining in tubular protein reabsorption droplets in minimal change disease and focal segmental glomerulosclerosis.
Bu L; Mirocha J; Haas M
Nephrol Dial Transplant; 2021 May; 36(6):1016-1022. PubMed ID: 32191308
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of glomerular C4d staining in patients with IgA nephritis.
Sahin OZ; Yavas H; Taslı F; Gibyeli DG; Ersoy R; Uzum A; Cirit M
Int J Clin Exp Pathol; 2014; 7(6):3299-304. PubMed ID: 25031752
[TBL] [Abstract][Full Text] [Related]
17. Reduced INF2 expression in nephrotic syndrome is possibly related to clinical severity of steroid resistance in children.
Tamura H; Nakazato H; Kuraoka S; Yoneda K; Takahashi W; Endo F
Nephrology (Carlton); 2016 Jun; 21(6):467-75. PubMed ID: 26383224
[TBL] [Abstract][Full Text] [Related]
18. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
[TBL] [Abstract][Full Text] [Related]
19. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[TBL] [Abstract][Full Text] [Related]
20. C4d as a diagnostic tool in membranous nephropathy.
Espinosa-Hernández M; Ortega-Salas R; López-Andreu M; Gómez-Carrasco JM; Pérez-Sáez MJ; Pérez-Seoane C; Aljama-García P
Nefrologia; 2012 May; 32(3):295-9. PubMed ID: 22592419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
